Grais Linda S
SEC-identified person · CIK 1413306 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Corvus Pharmaceuticals, Inc. CRVS | Director | filed 2019 - 2026 |
| Icon PLC ICLR | Director | filed 2026 - 2026 |
| Oruka Therapeutics, Inc. ORKA | Director | filed 2009 - 2024 |
| PRA Health Sciences, Inc. PRAH | Director | filed 2015 - 2021 |
| Zosano Pharma Corp ZSAN | Director | filed 2019 - 2021 |
| Deerfield Healthcare Technology Acquisitions Corp. DFHT | Director | filed 2020 - 2020 |
| Tranzyme INC TZYM | Director · President and CEO | filed 2013 - 2017 |
| Trius Therapeutics Inc TSRX | Officer | filed 2010 - 2010 |
| Reshape Weightloss Inc. etrm | Officer | filed 2007 - 2007 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.